Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Chemotherapy and Pharmacology
Published in: Cancer Chemotherapy and Pharmacology 4/2002

01-10-2002 | Original Article

Phage-displayed random peptide libraries in mice: toxicity after serial panning

Authors: David N. Krag, Susan P. Fuller, Lyn Oligino, Stephanie C. Pero, Donald L. Weaver, Amy L. Soden, Christopher Hebert, Sadie Mills, Chen Liu, Daniel Peterson

Published in: Cancer Chemotherapy and Pharmacology | Issue 4/2002

Login to get access
Metadata
Title
Phage-displayed random peptide libraries in mice: toxicity after serial panning
Authors
David N. Krag
Susan P. Fuller
Lyn Oligino
Stephanie C. Pero
Donald L. Weaver
Amy L. Soden
Christopher Hebert
Sadie Mills
Chen Liu
Daniel Peterson
Publication date
01-10-2002
Publisher
Springer-Verlag
Published in
Cancer Chemotherapy and Pharmacology / Issue 4/2002
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-002-0489-4

Other articles of this Issue 4/2002

Cancer Chemotherapy and Pharmacology 4/2002 Go to the issue

Erratum

Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles

Original Article

Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed

Original Article

Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens

Original Article

Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity

Original Article

Preoperative cisplatin for initial treatment of limb osteosarcoma: its local effect and impact on prognosis

Original Article

Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits